South Korea’s Biosimilar Boom Enters High-Stakes ‘Third Wave’
South Korea’s Biosimilar Boom Enters High-Stakes ‘Third Wave’ April 1, 2026 | Wednesday | Analysis | By Ayesha…
Korea aims to double biopharma exports by 2030 and develop three blockbuster new drugs
Korea aims to double biopharma exports by 2030 and develop three blockbuster new drugs September 12, 2025 |…
Biocon Biologics Receives Health Canada Approval for
TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 (GLOBE NEWSWIRE) — Biocon Biologics Ltd. (BBL), a…
South Korea urges US to exempt pharma, allies from tariffs
South Korean government and biopharmaceutical industry representatives urged American policymakers May 7 to refrain from imposing tariffs on…
South Korea approves record number of biosimilars in 2024
To read the full story, subscribe or sign in. May 6, 2025 By Marian (YoonJee) Chu South Korea’s…
South Korea approves record number of biosimilars in 2024
To read the full story, subscribe or sign in. April 30, 2025 By Marian (YoonJee) Chu South Korea’s…
Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
INCHEON, South Korea, December 15, 2024–(BUSINESS WIRE)–Celltrion today announced that the Committee for Medicinal Products for Human Use…